Search Results for "Nicotine Patch Bioequivalence Study"
Original Source: Bioequivalence Between Nicotine Replacement Products and Nicorette® Gum
Bioequivalence between oral nicotine replacement products and Nicorette® gum.
Matching Channels
SERAPHIN - STUDY WITH ENDOTHELIN RECEPTOR ANTAGONIST IN PULMONARY ARTERIAL HYPERTENSION TO IMPROVE CLINICAL OUTCOME. SERAPHIN (Study with an Endothelin Rece...
Because of the addictive properties of components of cigarettes, giving up the habit of smoking is often very hard. It is often required however for health reasons. There is a lot of publicity of...
Hepatology is the study of liver, gallbladder, biliary tree, and pancreas, and diseases associated with them. This includes viral hepatitis, alcohol damage, cirrhosis and cancer. As modern lifestyle...
Pain is defined by the International Association for the Study of Pain as “an unpleasant sensory and emotional experience associated with actual or potential tissue damage or described in term...
Gynecology is the study of diseases affecting the reproductive organs of women and girls. Add the Gynecology News Channel to your RSS reader;
Matching News
Nicotine patch shows benefits in mild cognitive impairment, study suggests
Using a nicotine patch may help improve mild memory loss in older adults, according to a new study.
Nicotine patch safe after heart attack, study suggests
NEW YORK (Reuters Health) - Nicotine replacement therapy appears to be safe for people discharged from the hospital after suffering a heart attack or angina, according to a small new study.
Champix better than patches for smoking cessation
New research shows that Pfizer’s Champix is better than nicotine patch therapy at helping smokers kick the habit. A Pfizer UK commissioned meta-analysis showed that patients taking Champix were sign...
FDA Gives Nod to Longer Use of Nicotine Patch, Gum
MONDAY, April 1 (HealthDay News) -- Smokers who are trying to quit can use over-the-counter nicotine replacement gums, lozenges and skin patches for a longer period of time than previously recommended...
Nicotine patch safe after heart attack: study
NEW YORK (Reuters Health) - Nicotine replacement therapy appears to be safe for people discharged from the hospital after suffering a heart attack or chest pains, according to a small new study.
Nicotine Vaccine Promising for Smoking Cessation
A nicotine vaccine reduces the amount of nicotine that reaches the brain, subsequent cigarette use and cravings, a new study shows. Medscape Medical News
FDA Approving More ANDAs That Use Novel Bioequivalence Methods
OGD officials report on the progress being made in approving generic drugs using more novel and science-based bioequivalence methods than in the past. Officials impart tips on how to submit review-rea...
Azaya Therapeutics commences ATI-0918 bioequivalence study in ovarian cancer
Azaya Therapeutics, Inc. today announced the initiation of a bioequivalence study of ATI-0918 in patients with ovarian cancer.
Matching PubMed Articles
Real-Time UV Imaging of Nicotine Release from Transdermal Patch.
PURPOSE: This study was conducted to characterize UV imaging as a platform for performing in vitro release studies using Nicorette(R) nicotine patches as a model drug delivery system. METHODS: The rat...
Continuing to wear nicotine patches after smoking lapses promotes recovery of abstinence.
Aims: Smokers who lapse during a cessation attempt are at particularly high risk of relapse, so interventions to help smokers recover from lapses are urgently needed. Two recent studies have sugges...
Effect of local controlled heat on transdermal delivery of nicotine.
Skin permeability and local blood perfusion are important factors for transdermal drug delivery. Application of heat is expected to enhance microcirculation and local perfusion and/or blood vessel per...
Effect of social stress during acute nicotine abstinence.
RATIONALE: Relapse to smoking is often precipitated by stress, yet little is known about the effects of nicotine withdrawal on responses to acute stress, or whether nicotine replacement reverses withd...
In the European Union multiple dose bioequivalence studies are required for the approval of generic prolonged-release products, but they are not required by the US-FDA. In order to investigate if the...
